Brotons, C, Moral, I. Vascular age: a tool to facilitate communication with patients about cardiovascular risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500936. PMID:41991403. IF:(Q/D).

Cáceres, A, Carreras, G, Pérez-Jurado, LA. Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up. CLINICAL ENDOCRINOLOGY. 2026; 104(5)DOI:10.1111/cen.70089. PMID:41473979. IF:2.400(Q3/7D).

Arnau, ABM, Jose, LEGS, Santos, VM, Sánchez-Cabús, S. Transcystic approach in the management of choledocholithiasis: intraoperative complications and technical considerations. CIRUGIA ESPANOLA. 2026; 104(5)DOI:10.1016/j.ciresp.2026.800312. PMID:. IF:1.300(Q3/7D).

Alijotas-Reig, J, Esteve-Valverde, E, Sáez-Comet, L, Anunciación-Llunell, A, Ferrer-Oliveras, R, Lefkou, E, Mekinian, A, Belizna, C, Hoxha, A, Tincani, A, Marozio, L, Espinosa, G, de Carolis, S, Udry, S, Latino, JO, Llurba, E, Chighizola, CB, Gerosa, M, Pengo, V, Lundelin, K, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Reshetnyak, T, Tabacco, S, Stojanovich, L, Gonçalves, BA, Morales-Perez, S, Miró-Mur, F. Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2026; 321DOI:10.1016/j.ejogrb.2026.115055. PMID:41797084. IF:1.900(Q2/5D).